Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Jul 19, 2024; 14(7): 1062-1067
Published online Jul 19, 2024. doi: 10.5498/wjp.v14.i7.1062
Published online Jul 19, 2024. doi: 10.5498/wjp.v14.i7.1062
Clinical study of chemotherapy-related cognitive impairment in patients with non-Hodgkin lymphoma
Qiang-Li Wang, Hai-Yan Xu, Yi Wang, Yin-Ling Wang, Pei-Nan Lin, Zhong-Lei Chen, Department of Oncology and Hematology, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215000, Jiangsu Province, China
Author contributions: Wang QL and Chen ZL designed the study; Wang QL, Chen ZL, Xu HY, Wang Y, Wang YL, and Lin PN performed the research; Wang QL, Chen ZL, Xu HY, Wang Y, Wang YL, and Lin PN contributed new reagents and analytical tools; Wang QL and Chen ZL analyzed the data and wrote the manuscript; All authors have read and approved the final version of the manuscript.
Institutional review board statement: The study was reviewed and approved by the (Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine) Institutional Review Board.
Informed consent statement: All study participants or their legal guardians provided written informed consent prior to their participation in this study.
Conflict-of-interest statement: All authors declare that they have nothing to disclose.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE statement-checklist of items, and the manuscript was prepared and revised according to the STROBE statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhong-Lei Chen, MMed, Associate Chief Physician, Department of Oncology and Hematology, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, No. 118 WanSheng Street, Suzhou 215000, Jiangsu Province, China.
Received: April 8, 2024
Revised: May 7, 2024
Accepted: May 30, 2024
Published online: July 19, 2024
Processing time: 94 Days and 18.2 Hours
Revised: May 7, 2024
Accepted: May 30, 2024
Published online: July 19, 2024
Processing time: 94 Days and 18.2 Hours
Core Tip
Core Tip: The cognitive status of patients with non-Hodgkin’s lymphoma before and after chemotherapy was assessed using various cognitive scales. We observed chemotherapy-related cognitive impairment. Patients with non-Hodgkin’s lymphoma undergoing chemotherapy may experience chemotherapy-related cognitive impairment. The main manifestations were language, memory, and visuospatial dysfunction. Frontal lobe injury was more obvious, but no clear difference was observed in executive function.